Internal Medicine, Interventional Cardiology · Redding, CA
NPI
1649230988
Since 2006
Specialty
Internal Medicine, Interventional Cardiology
Code 207RI0011X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
2425 Sonoma Street
Redding, CA, 96001
Phone (530) 241-1144
Groups this clinician bills Medicare through
Medicare paid, 2024
$5.4M
38,741 services
Medicare patients, 2024
6,686
Average age 75
Drug cost, 2024
$8.0M
25,643 prescriptions
Company payments, 2025
$24K
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mohamed H Khan was code J2785 (injection, regadenoson, 0.1 mg), 7,140 times for 1,783 patients. In total Mohamed H Khan billed 38,741 services in 133 codes, and Medicare paid $5.4M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-04-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2785 Injection, regadenoson, 0.1 mg | Office | 7,140 | 1,783 | $5.42 | $39K |
| 93000 Electrocardiogram | Office | 4,825 | 3,447 | $10.36 | $50K |
| 93306 Echocardiography (TTE/TEE) | Office | 3,170 | 3,071 | $152.89 | $485K |
| A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2,854 | 1,426 | $414.67 | $1.2M |
| 99214 Office E&M - Established | Office | 2,667 | 2,088 | $91.11 | $243K |
| 93015 Electrocardiogram | Office | 2,222 | 2,196 | $57.56 | $128K |
| 99213 Office E&M - Established | Office | 1,654 | 1,506 | $64.94 | $107K |
| 78492 Myocardial Perfusion Scan | Office | 1,427 | 1,426 | $1,230.73 | $1.8M |
| 93880 Duplex Scan - Extracranial Arteries | Office | 1,394 | 1,333 | $148.58 | $207K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,108 | 926 | $12.88 | $14K |
| 93356 Echocardiography (TTE/TEE) | Office | 913 | 898 | $30.00 | $27K |
| 93224 Electrocardiogram | Office | 890 | 873 | $55.81 | $50K |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 838 | 419 | $89.60 | $75K |
| 93280 External Electrocardiographic Monitoring | Office | 838 | 641 | $56.13 | $47K |
| 93296 External Electrocardiographic Monitoring | Office | 773 | 302 | $18.14 | $14K |
By year: 2022 $5.6M for 37,259 services; 2023 $5.7M for 40,460 services; 2024 $5.4M for 38,741 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mohamed H Khan prescribed most often to Medicare patients was Atorvastatin Calcium, with 2,676 prescriptions and refills. In total Mohamed H Khan wrote 25,643 Medicare prescriptions that cost $8.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 2,676 | 7,616 | 810 | $26K |
| Eliquis Apixaban | 2,431 | 6,052 | 716 | $3.5M |
| Metoprolol Succinate Generic | 1,973 | 5,544 | 640 | $32K |
| Rosuvastatin Calcium Generic | 1,590 | 4,532 | 520 | $36K |
| Losartan Potassium Generic | 1,323 | 3,739 | 417 | $12K |
| Carvedilol Generic | 1,102 | 3,091 | 358 | $10K |
| Entresto Sacubitril/Valsartan | 927 | 2,239 | 282 | $1.4M |
| Lisinopril Generic | 850 | 2,424 | 263 | $7,616 |
| Furosemide Generic | 827 | 2,354 | 308 | $5,528 |
| Amlodipine Besylate Generic | 823 | 2,351 | 281 | $4,743 |
| Metoprolol Tartrate Generic | 796 | 2,215 | 267 | $6,434 |
| Spironolactone Generic | 782 | 2,181 | 264 | $6,802 |
| Xarelto Rivaroxaban | 691 | 1,691 | 194 | $924K |
| Sotalol Sotalol Hcl | 605 | 1,705 | 196 | $9,853 |
| Ezetimibe Generic | 541 | 1,523 | 178 | $19K |
Brand drugs: 5,803 claims; generic drugs: 19,840 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mohamed H Khan $24K ($24K in general payments such as food, travel and fees) from 21 companies. The largest payer was AngioDynamics, Inc. with $22K.
| Company | Payments | Amount |
|---|---|---|
| AngioDynamics, Inc. ANGO | 1 | $22K |
| Abbott Laboratories ABT | 12 | $467 |
| Boston Scientific Corporation BSX | 5 | $351 |
| Edwards Lifesciences Corporation EW | 6 | $276 |
| Novartis Pharmaceuticals Corporation NVS | 11 | $206 |
| Kestra Medical Technology Services, Inc. | 4 | $205 |
| Merck Sharp & Dohme LLC MRK | 10 | $204 |
| Actelion Pharmaceuticals US, Inc. JNJ | 3 | $157 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $143 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $109 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.